Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$49.75
-0.94-1.85%
At close: -
$49.80
0.050.10%
After Hours: Jun 13, 7:56 PM EDT
Comments
Loading...
Bristol-Myers Squibb Analyst Ratings and Price Targets | NYSE:BMY | Benzinga
Bristol-Myers Squibb Co has a consensus price target of $61.5 based on the ratings of 31 analysts. The high is $85 issued by Atlantic Equities on July 28, 2023. The low is $39 issued by Morgan Stanley on November 12, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, Cantor Fitzgerald, and Jefferies on April 28, 2025, April 23, 2025, and April 23, 2025, respectively. With an average price target of $58.67 between Wells Fargo, Cantor Fitzgerald, and Jefferies, there's an implied 17.80% upside for Bristol-Myers Squibb Co from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Cantor Fitzgerald
Jefferies
Piper Sandler
UBS
1calculated from analyst ratings
Analyst Ratings for Bristol-Myers Squibb
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/28/2025 | Buy Now | 6.43% | Wells Fargo | Mohit Bansal68% | $62 → $53 | Maintains | Equal-Weight | Get Alert |
| 04/23/2025 | Buy Now | 10.44% | Cantor Fitzgerald | Carter Gould55% | $55 → $55 | Reiterates | Neutral → Neutral | Get Alert |
| 04/23/2025 | Buy Now | 36.55% | Jefferies | Akash Tewari42% | $70 → $68 | Maintains | Buy | Get Alert |
| 04/22/2025 | Buy Now | 30.52% | Piper Sandler | David Amsellem74% | → $65 | Initiates | → Overweight | Get Alert |
| 04/22/2025 | Buy Now | 10.44% | Cantor Fitzgerald | Carter Gould55% | → $55 | Assumes | → Neutral | Get Alert |
| 04/11/2025 | Buy Now | 8.43% | UBS | Trung Huynh71% | $60 → $54 | Maintains | Neutral | Get Alert |
| 04/08/2025 | Buy Now | 10.44% | Goldman Sachs | Asad Haider 59% | $67 → $55 | Downgrade | Buy → Neutral | Get Alert |
| 02/07/2025 | Buy Now | 24.5% | Wells Fargo | Mohit Bansal68% | $60 → $62 | Maintains | Equal-Weight | Get Alert |
| 02/04/2025 | Buy Now | 10.44% | Cantor Fitzgerald | Olivia Brayer53% | $50 → $55 | Maintains | Neutral | Get Alert |
| 01/28/2025 | Buy Now | 30.52% | Citigroup | Andrew Baum70% | $60 → $65 | Maintains | Neutral | Get Alert |
| 01/08/2025 | Buy Now | 30.52% | Truist Securities | Robyn Karnauskas54% | $62 → $65 | Maintains | Buy | Get Alert |
| 12/16/2024 | Buy Now | 40.56% | Jefferies | Akash Tewari42% | $63 → $70 | Upgrade | Hold → Buy | Get Alert |
| 12/10/2024 | Buy Now | 26.51% | B of A Securities | Tim Anderson67% | → $63 | Reinstates | → Neutral | Get Alert |
| 11/15/2024 | Buy Now | — | Wolfe Research | Alexandria Hammond48% | — | Initiates | → Peer Perform | Get Alert |
| 11/12/2024 | Buy Now | 20.48% | Citigroup | Andrew Baum70% | $55 → $60 | Maintains | Neutral | Get Alert |
| 11/12/2024 | Buy Now | 22.49% | BMO Capital | Evan Seigerman63% | $57 → $61 | Maintains | Market Perform | Get Alert |
| 11/12/2024 | Buy Now | 46.59% | Leerink Partners | David Risinger72% | $55 → $73 | Upgrade | Market Perform → Outperform | Get Alert |
| 11/12/2024 | Buy Now | -21.69% | Morgan Stanley | Terence Flynn66% | $36 → $39 | Maintains | Underweight | Get Alert |
| 11/01/2024 | Buy Now | 14.46% | BMO Capital | Evan Seigerman63% | $53 → $57 | Maintains | Market Perform | Get Alert |
| 10/25/2024 | Buy Now | 10.44% | Citigroup | Andrew Baum70% | $75 → $55 | Downgrade | Buy → Neutral | Get Alert |
| 10/18/2024 | Buy Now | 0.4% | Cantor Fitzgerald | Olivia Brayer53% | $50 → $50 | Reiterates | Neutral → Neutral | Get Alert |
| 10/17/2024 | Buy Now | 12.45% | Bernstein | — | → $56 | Initiates | → Market Perform | Get Alert |
| 10/09/2024 | Buy Now | 8.43% | UBS | Trung Huynh71% | $50 → $54 | Maintains | Neutral | Get Alert |
| 10/07/2024 | Buy Now | -13.65% | Barclays | Carter Gould55% | $42 → $43 | Maintains | Underweight | Get Alert |
| 10/07/2024 | Buy Now | 18.47% | TD Cowen | Steve Scala67% | $53 → $59 | Maintains | Hold | Get Alert |
| 09/27/2024 | Buy Now | 6.43% | BMO Capital | Evan Seigerman63% | $48 → $53 | Maintains | Market Perform | Get Alert |
| 09/23/2024 | Buy Now | -3.61% | BMO Capital | Evan Seigerman63% | $48 → $48 | Maintains | Market Perform | Get Alert |
| 09/16/2024 | Buy Now | 0.4% | Cantor Fitzgerald | Olivia Brayer53% | $50 → $50 | Reiterates | Neutral → Neutral | Get Alert |
| 08/28/2024 | Buy Now | 2.41% | Jefferies | Akash Tewari42% | $49 → $51 | Maintains | Hold | Get Alert |
| 08/22/2024 | Buy Now | -15.66% | Barclays | Carter Gould55% | $41 → $42 | Maintains | Underweight | Get Alert |
| 08/12/2024 | Buy Now | 6.43% | TD Cowen | Steve Scala67% | $45 → $53 | Maintains | Hold | Get Alert |
| 07/29/2024 | Buy Now | -17.67% | Barclays | Carter Gould55% | $41 → $41 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/23/2024 | Buy Now | -9.64% | Deutsche Bank | James Shin51% | $53 → $45 | Maintains | Hold | Get Alert |
| 07/22/2024 | Buy Now | -9.64% | Cantor Fitzgerald | Olivia Brayer53% | $45 → $45 | Reiterates | Neutral → Neutral | Get Alert |
| 07/10/2024 | Buy Now | -17.67% | Barclays | Carter Gould55% | $43 → $41 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | -3.61% | BMO Capital | Evan Seigerman63% | $55 → $48 | Maintains | Market Perform | Get Alert |
| 04/26/2024 | Buy Now | -13.65% | Barclays | Carter Gould55% | $51 → $43 | Maintains | Equal-Weight | Get Alert |
| 04/18/2024 | Buy Now | 4.42% | Wells Fargo | Mohit Bansal68% | $51 → $52 | Maintains | Equal-Weight | Get Alert |
| 02/06/2024 | Buy Now | 2.41% | Wells Fargo | Mohit Bansal68% | $58 → $51 | Maintains | Equal-Weight | Get Alert |
| 02/06/2024 | Buy Now | 8.43% | Redburn Atlantic | Steve Chesney53% | $77 → $54 | Downgrade | Buy → Neutral | Get Alert |
| 01/03/2024 | Buy Now | 20.48% | B of A Securities | Geoff Meacham62% | $68 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 12/27/2023 | Buy Now | 36.55% | B of A Securities | Geoff Meacham62% | $72 → $68 | Maintains | Buy | Get Alert |
| 11/15/2023 | Buy Now | 10.44% | Cantor Fitzgerald | Olivia Brayer53% | $68 → $55 | Downgrade | Overweight → Neutral | Get Alert |
| 11/09/2023 | Buy Now | 10.44% | Deutsche Bank | James Shin51% | → $55 | Initiates | → Hold | Get Alert |
| 11/02/2023 | Buy Now | 8.43% | Daiwa Capital | Narumi Nakagiri23% | $68 → $54 | Downgrade | Outperform → Neutral | Get Alert |
| 10/30/2023 | Buy Now | 38.55% | Goldman Sachs | Chris Shibutani56% | $81 → $69 | Maintains | Buy | Get Alert |
| 10/27/2023 | Buy Now | 0.4% | Morgan Stanley | Terence Flynn66% | $56 → $50 | Maintains | Underweight | Get Alert |
| 10/27/2023 | Buy Now | 2.41% | Barclays | Carter Gould55% | $60 → $51 | Maintains | Equal-Weight | Get Alert |
| 10/27/2023 | Buy Now | 20.48% | BMO Capital | Evan Seigerman63% | → $60 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/27/2023 | Buy Now | — | William Blair | Matt Phipps25% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/27/2023 | Buy Now | 6.43% | HSBC | Rajesh Kumar61% | $55 → $53 | Upgrade | Reduce → Hold | Get Alert |
| 10/20/2023 | Buy Now | 20.48% | UBS | Trung Huynh71% | $70 → $60 | Assumes | Neutral → Neutral | Get Alert |
| 10/11/2023 | Buy Now | 12.45% | Morgan Stanley | Terence Flynn66% | $57 → $56 | Maintains | Underweight | Get Alert |
| 10/09/2023 | Buy Now | 50.6% | Cantor Fitzgerald | Olivia Brayer53% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 10/06/2023 | Buy Now | 68.67% | Truist Securities | Robyn Karnauskas54% | → $84 | Reiterates | Buy → Buy | Get Alert |
| 09/15/2023 | Buy Now | 68.67% | Truist Securities | Gregg Gilbert58% | → $84 | Reiterates | Buy → Buy | Get Alert |
| 09/15/2023 | Buy Now | 32.53% | TD Cowen | Steve Scala67% | $80 → $66 | Maintains | Market Perform | Get Alert |
| 09/15/2023 | Buy Now | 50.6% | Cantor Fitzgerald | Olivia Brayer53% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 07/28/2023 | Buy Now | 30.52% | Wells Fargo | Mohit Bansal68% | $78 → $65 | Maintains | Equal-Weight | Get Alert |
| 07/28/2023 | Buy Now | 58.63% | BMO Capital | Evan Seigerman63% | $87 → $79 | Maintains | Outperform | Get Alert |
| 07/28/2023 | Buy Now | 60.64% | B of A Securities | Geoff Meacham62% | $85 → $80 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | 70.68% | Atlantic Equities | Steve Chesney53% | $90 → $85 | Maintains | Overweight | Get Alert |
| 07/28/2023 | Buy Now | 24.5% | Barclays | Carter Gould55% | $64 → $62 | Maintains | Equal-Weight | Get Alert |
| 07/20/2023 | Buy Now | 70.68% | Cantor Fitzgerald | Olivia Brayer53% | $88 → $85 | Maintains | Overweight | Get Alert |
| 07/19/2023 | Buy Now | 18.47% | Morgan Stanley | Terence Flynn66% | $59 → $59 | Reiterates | Underweight → Underweight | Get Alert |
| 07/14/2023 | Buy Now | 12.45% | HSBC | Rajesh Kumar61% | → $56 | Initiates | → Reduce | Get Alert |
| 07/11/2023 | Buy Now | 18.47% | Morgan Stanley | Terence Flynn66% | $59 → $59 | Reiterates | Underweight → Underweight | Get Alert |
| 07/11/2023 | Buy Now | 28.51% | Barclays | Carter Gould55% | $65 → $64 | Maintains | Equal-Weight | Get Alert |
| 07/10/2023 | Buy Now | 32.53% | SVB Leerink | David Risinger72% | → $66 | Initiates | → Market Perform | Get Alert |
| 06/28/2023 | Buy Now | 68.67% | Truist Securities | Gregg Gilbert58% | → $84 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2023 | Buy Now | 30.52% | Barclays | Carter Gould55% | $66 → $65 | Maintains | Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | 44.58% | Credit Suisse | Trung Huynh71% | $78 → $72 | Maintains | Neutral | Get Alert |
| 04/21/2023 | Buy Now | 70.68% | B of A Securities | Geoff Meacham62% | $82 → $85 | Maintains | Buy | Get Alert |
| 03/06/2023 | Buy Now | 24.5% | Jefferies | Akash Tewari42% | → $62 | Initiates | → Hold | Get Alert |
| 02/03/2023 | Buy Now | 24.5% | Morgan Stanley | Terence Flynn66% | $60 → $62 | Maintains | Underweight | Get Alert |
| 02/03/2023 | Buy Now | 80.72% | Atlantic Equities | Steve Chesney53% | $88 → $90 | Maintains | Overweight | Get Alert |
| 01/17/2023 | Buy Now | 90.76% | Cantor Fitzgerald | Olivia Brayer53% | → $95 | Initiates | → Overweight | Get Alert |
| 01/03/2023 | Buy Now | 56.63% | Wells Fargo | Mohit Bansal68% | $70 → $78 | Maintains | Equal-Weight | Get Alert |
| 11/18/2022 | Buy Now | 56.63% | Credit Suisse | Trung Huynh71% | → $78 | Initiates | → Neutral | Get Alert |
| 11/10/2022 | Buy Now | 76.71% | Atlantic Equities | Steve Chesney53% | $85 → $88 | Maintains | Overweight | Get Alert |
| 10/27/2022 | Buy Now | 20.48% | Morgan Stanley | Terence Flynn66% | $61 → $60 | Maintains | Underweight | Get Alert |
| 10/27/2022 | Buy Now | 70.68% | Atlantic Equities | Steve Chesney53% | $87 → $85 | Maintains | Overweight | Get Alert |
| 10/12/2022 | Buy Now | 32.53% | Barclays | Carter Gould55% | $69 → $66 | Maintains | Equal-Weight | Get Alert |
| 10/10/2022 | Buy Now | — | Guggenheim | Seamus Fernandez63% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/14/2022 | Buy Now | 52.61% | Berenberg | Luisa Hector53% | $82 → $76 | Downgrade | Buy → Hold | Get Alert |
| 09/12/2022 | Buy Now | 88.76% | BMO Capital | Evan Seigerman63% | $92 → $94 | Maintains | Outperform | Get Alert |
| 09/12/2022 | Buy Now | 74.7% | Atlantic Equities | Steve Chesney53% | $83 → $87 | Maintains | Overweight | Get Alert |
| 07/28/2022 | Buy Now | 22.49% | Morgan Stanley | Terence Flynn66% | $63 → $61 | Maintains | Underweight | Get Alert |
| 07/28/2022 | Buy Now | 50.6% | UBS | Colin Bristow38% | $73 → $75 | Maintains | Neutral | Get Alert |
| 07/28/2022 | Buy Now | 66.67% | Atlantic Equities | Steve Chesney53% | $82 → $83 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Bristol-Myers Squibb (BMY) stock?
The latest price target for Bristol-Myers Squibb (NYSE:BMY) was reported by Wells Fargo on April 28, 2025. The analyst firm set a price target for $53.00 expecting BMY to rise to within 12 months (a possible 6.43% upside). 35 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bristol-Myers Squibb (BMY)?
The latest analyst rating for Bristol-Myers Squibb (NYSE:BMY) was provided by Wells Fargo, and Bristol-Myers Squibb maintained their equal-weight rating.
When was the last upgrade for Bristol-Myers Squibb (BMY)?
The last upgrade for Bristol-Myers Squibb Co happened on December 16, 2024 when Jefferies raised their price target to $70. Jefferies previously had a hold for Bristol-Myers Squibb Co.
When was the last downgrade for Bristol-Myers Squibb (BMY)?
The last downgrade for Bristol-Myers Squibb Co happened on April 8, 2025 when Goldman Sachs changed their price target from $67 to $55 for Bristol-Myers Squibb Co.
When is the next analyst rating going to be posted or updated for Bristol-Myers Squibb (BMY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bristol-Myers Squibb, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bristol-Myers Squibb was filed on April 28, 2025 so you should expect the next rating to be made available sometime around April 28, 2026.
Is the Analyst Rating Bristol-Myers Squibb (BMY) correct?
While ratings are subjective and will change, the latest Bristol-Myers Squibb (BMY) rating was a maintained with a price target of $62.00 to $53.00. The current price Bristol-Myers Squibb (BMY) is trading at is $49.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
